Article Document Academic Article Information Content Entity Journal Article Continuant Continuant Entity Entity Generically Dependent Continuant 2025-05-06T21:52:43 RDF description of SARS-CoV-2 antiviral prescribing gaps among non-hospitalized high-risk adults - http://repository.healthpartners.com/individual/document-rn34597 Risk Factors Hospitalization public 37846 Coronavirus Infections Physician's Practice Patterns document-rn34597 2024-01-31T20:36:01.869-06:00 78 Drugs and Drug Therapy Clinical Infectious Diseases <p>Within a multi-state clinical cohort, SARS-CoV-2 antiviral prescribing patterns were evaluated from April 2022-June 2023 among non-hospitalized SARS-CoV-2-infected patients with risk factors for severe COVID-19. Among 3,247 adults, only 31.9% were prescribed an antiviral agent (87.6% nirmatrelvir/ritonavir, 11.9% molnupiravir, 0.5% remdesivir), highlighting the need to identify and address treatment barriers.<p> 22033 10.1093/cid/ciad796 SARS-CoV-2 antiviral prescribing gaps among non-hospitalized high-risk adults 6 COVID-19